Curis
CRIS
#11106
Rank
NZ$1.14 M
Marketcap
NZ$0.59
Share price
-17.89%
Change (1 day)
-78.27%
Change (1 year)

Earnings for Curis (CRIS)

Earnings in 2026 (TTM): -NZ$11.08 Million

According to Curis's latest financial reports the company's current earnings are NZ$7.06 Million. In 2025 the company made an earning of -NZ$9.16 Million, an increase over its 2024 earnings that were of -NZ$72.56 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Curis from 2001 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$11.08 Million21.03%
2025 -NZ$9.16 Million-87.38%
2024 -NZ$72.56 Million-5.77%
2023 -NZ$77.01 Million-13.1%
2022 -NZ$88.61 Million27.52%
2021 -NZ$69.49 Million65.09%
2020 -NZ$42.1 Million-9.1%
2019 -NZ$46.31 Million-4.73%
2018 -NZ$48.6 Million-41.95%
2017 -NZ$83.72 Million-14.37%
2016 -NZ$97.77 Million3.55%
2015 -NZ$94.41 Million271.52%
2014 -NZ$25.42 Million76.64%
2013 -NZ$14.39 Million
2011 -NZ$12.22 Million27.76%
2010 -NZ$9.57 Million-43.87%
2009 -NZ$17.04 Million-23.44%
2008 -NZ$22.26 Million56.66%
2007 -NZ$14.21 Million-16.71%
2006 -NZ$17.06 Million-36.92%
2005 -NZ$27.04 Million156.25%
2004 -NZ$10.56 Million-37.24%
2003 -NZ$16.82 Million-93.34%
2002 -NZ$0.26 Billion86.79%
2001 -NZ$0.14 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
NZ$17.96 B-156,794.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$16.27 B-142,088.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-NZ$0.11 Billion 815.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
NZ$1.70 B-14,942.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-NZ$0.53 Billion 4,472.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-NZ$37.65 Million 228.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$0.10 B-974.39%๐Ÿ‡บ๐Ÿ‡ธ USA